0001144204-16-135202.txt : 20161117 0001144204-16-135202.hdr.sgml : 20161117 20161117164550 ACCESSION NUMBER: 0001144204-16-135202 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161117 DATE AS OF CHANGE: 20161117 EFFECTIVENESS DATE: 20161117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Protea Biosciences Group, Inc. CENTRAL INDEX KEY: 0001335103 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-274750 FILM NUMBER: 162005456 BUSINESS ADDRESS: STREET 1: 1311 PINEVIEW DRIVE STREET 2: SUITE 501 CITY: MORGANTOWN STATE: WV ZIP: 26505 BUSINESS PHONE: 304 292-2226 MAIL ADDRESS: STREET 1: 1311 PINEVIEW DRIVE STREET 2: SUITE 501 CITY: MORGANTOWN STATE: WV ZIP: 26505 FORMER COMPANY: FORMER CONFORMED NAME: Protea Biosciences Inc. DATE OF NAME CHANGE: 20110908 FORMER COMPANY: FORMER CONFORMED NAME: SRKP 5 INC DATE OF NAME CHANGE: 20050803 D 1 primary_doc.xml X0707 D LIVE 0001335103 Protea Biosciences Group, Inc. 1311 PINEVIEW DRIVE SUITE 501 MORGANTOWN WV WEST VIRGINIA 26505 304 292-2226 DELAWARE SRKP 5, Inc. Protea Biosciences Inc. SRKP 5 INC Corporation true Stephen A. Turner c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer Director CEO, Chairman of the Board of Directors David Halverson c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer President and Chief Business Officer Stanley Hostler c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer Director Secretary Ed Roberson c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Scott Segal c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Josiah T. Austin c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Patrick Gallagher c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Maged Shenouda c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Matthew Powell c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Executive Officer Vice President, Research & Development Steve Antoline c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Steve Harris c/o Protea Biosciences Group, Inc. 1311 Pineview Drive, Suite 501 Morgantown WV WEST VIRGINIA 26505 Director Biotechnology $1,000,001 - $5,000,000 06b false 2016-11-03 false true true false 10000 Laidlaw & Company (UK) Ltd. 119037 None None 546 FIFTH AVENUE 5TH FLOOR NEW YORK NY NEW YORK 10036 AZ ARIZONA CA CALIFORNIA GA GEORGIA KS KANSAS KY KENTUCKY MD MARYLAND MN MINNESOTA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OK OKLAHOMA TX TEXAS WA WASHINGTON WV WEST VIRGINIA false 5000000 631680 4368320 false 25 95842 0 Included in the sales commission is a non-accountable expense allowance. Laidlaw also received three-year warrants to purchase 2,278,720 shares of common stock of the Issuer, with an exercise price of $0.09 per share. 0 false Protea Biosciences Group, Inc. /s/ Stephen A. Turner Stephen A. Turner CEO, Chairman of the Board 2016-11-17